Mitigation of autophagy ameliorates hepatocellular damage following ischemia-reperfusion injury in murine steatotic liver

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 307, Issue 11, 2014, Pages G1088-G1099

  Gupta, Nitika A ^a,b   Kolachala, Vasantha L ^a   Jiang, Rong ^a   Abramowsky, Carlos ^a   Shenoi, Asha ^a,b   Kosters, Astrid ^a   Pavuluri, Haritha ^a   Anania, Frank ^a   Kirk, Allan D ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Transplant Services Children s Healthcare of Atlanta   (United States)

Author keywords

Autophagy; Ischemia reperfusion injury; Steatosis

Indexed keywords

3 METHYLADENINE; BAFILOMYCIN A1; BECLIN 1; EXENDIN 4; HIGH MOBILITY GROUP B1 PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 5; PROTEIN P62; 3-METHYLADENINE; ADENINE; MACROLIDE; PEPTIDE; VENOM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; FATTY LIVER; IN VITRO STUDY; LIPID DIET; LIVER CELL; LIVER CELL CULTURE; LIVER CELL DAMAGE; LIVER MITOCHONDRION; MALE; MOUSE; NONHUMAN; REPERFUSION INJURY; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; ENZYMOLOGY; HUMAN; NONALCOHOLIC FATTY LIVER; PATHOLOGY;

ADENINE; ANIMALS; AUTOPHAGY; CELLS, CULTURED; HEPATOCYTES; HUMANS; MACROLIDES; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA, LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; PEPTIDES; REPERFUSION INJURY; VENOMS;

EID: 84913589360     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00210.2014     Document Type: Article

References (59)

1. Altman BJ, Rathmell JC. Autophagy: not good OR bad, but good AND bad. Autophagy5: 569–570, 2009.
2. Amir M, Czaja MJ. Autophagy in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol5: 159–166, 2011.
3. Axe EL, Walker SA, Manifava M, Chandra P, Roderick HL, Haber-mann A, Griffiths G, Ktistakis NT. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol182: 685–701, 2008.
4. Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. Circulation117: 2340–2350, 2008.
5. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg2: 292–298, 1998.
6. Bose AK, Mocanu MM, Carr RD, Yellon DM. Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway. Cardiovasc Drugs Ther21: 253–256, 2007.
7. Bursch W, Ellinger A, Gerner C, Frohwein U, Schulte-Hermann R. Programmed cell death (PCD) apoptosis, autophagic PCD, or others? Ann NY Acad Sci926: 1–12, 2000.
8. Cardinal J, Pan P, Tsung A. Protective role of cisplatin in ischemic liver injury through induction of autophagy. Autophagy5: 1211–1212, 2009.
9. Chen Y, Klionsky DJ. The regulation of autophagy—unanswered questions. J Cell Sci124: 161–170, 2011.
10. Clavien PA, Selzner M. Hepatic steatosis and transplantation. Liver Transplant8: 980, 2002.
11. Cole A, Armour EP. Ultrastructural study of mitochondrial damage in CHO cells exposed to hyperthermia. Radiat Res115: 421–435, 1988.
12. Cuervo AM. Autophagy: in sickness and in health. Trends Cell Biol14: 70–77, 2004.
13. Czaja MJ, Ding WX, Donohue TM, Friedman SL, Kim JS, Komatsu M, Lemasters JJ, Lemoine A, Lin JD, Ou JH, Perlmutter DH, Randall G, Ray RB, Tsung A, Yin XM. Functions of autophagy in normal and diseased liver. Autophagy9: 1131–1158, 2013.
14. Degli Esposti D, Sebagh M, Pham P, Reffas M, Pous C, Brenner C, Azoulay D, Lemoine A. Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes. Cell Death Dis2: e111, 2011.
15. Ding X, Saxena NK, Lin S, Gupta NA, Anania FA. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steato-sis in ob/ob mice. Hepatology43: 173–181, 2006.
16. Dong H, Czaja MJ. Regulation of lipid droplets by autophagy. Trends Endocrinol Metab22: 234–240, 2011.
17. Emadali A, Muscatelli-Groux B, Delom F, Jenna S, Boismenu D, Sacks DB, Metrakos PP, Chevet E. Proteomic analysis of ischemia-reperfusion injury upon human liver transplantation reveals the protective role of IQGAP1. Mol Cell Proteomics5: 1300–1313, 2006.
18. Evankovich J, Zhang R, Cardinal JS, Zhang L, Chen J, Huang H, Beer-Stolz D, Billiar TR, Rosengart MR, Tsung A. Calcium/calmodu-lin-dependent protein kinase IV limits organ damage in hepatic ischemia-reperfusion injury through induction of autophagy. Am J Physiol Gastro-intest Liver Physiol303: G189–G198, 2012.
19. Evans ZP, Ellett JD, Schmidt MG, Schnellmann RG, Chavin KD. Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion. J Biol Chem283: 8573–8579, 2008.
20. Gupta NA, Kolachala VL, Jiang R, Abramowsky C, Romero R, Fifadara N, Anania F, Knechtle S, Kirk A. The glucagon-like peptide-1 receptor agonist, exendin 4, has a protective role in ischemic injury of lean and steatotic liver by inhibiting cell death and stimulating lipolysis. Am J Pathol181: 1693–1701, 2012.
21. Gupta NA, Mells J, Dunham RM, Grakoui A, Handy J, Saxena NK, Anania FA. Glucagon-like peptide-1 receptor is present on human hepa-tocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway. Hepatology51: 1584–1592, 2010.
22. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet43: 67–93, 2009.
23. Hnilicova J, Jirat Matejckova J, Sikova M, Pospisil J, Halada P, Panek J, Krasny L. Ms1, a novel sRNA interacting with the RNA polymerase core in mycobacteria. Nucleic Acids Res42: 11763–11776, 2015.
24. Jaeschke H. Mechanisms of reperfusion injury after warm ischemia of the liver. J Hepatobiliary Pancreat Surg5: 402–408, 1998.
25. Jaeschke H. Reperfusion injury after warm ischemia or cold storage of the liver: role of apoptotic cell death. Transplant Proc34: 2656–2658, 2002.
26. Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, Overvatn A, McMahon M, Hayes JD, Johansen T. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem285: 22576–22591, 2010.
27. Kathiria AS, Butcher LD, Feagins LA, Souza RF, Boland CR, Theiss AL. Prohibitin 1 modulates mitochondrial stress-related autophagy in human colonic epithelial cells. PLos One7: e31231, 2012.
28. Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism and regulation. Antioxid Redox Signal20: 460–467, 2014.
29. Klionsky DJ. Finding autophagy: it’s a question of how you look at it. Autophagy9: 267, 2013.
30. Klionsky DJ, Baehrecke EH, Brumell JH, Chu CT, Codogno P, Cuervo AM, Debnath J, Deretic V, Elazar Z, Eskelinen EL, Fink-beiner S, Fueyo-Margareto J, Gewirtz D, Jaattela M, Kroemer G, Levine B, Melia TJ, Mizushima N, Rubinsztein DC, Simonsen A, Thorburn A, Thumm M, Tooze SA. A comprehensive glossary of autophagy-related molecules and processes (2nd ed.). Autophagy 7: 1273–1294, 2011.
31. Kobayashi S, Xu X, Chen K, Liang Q. Suppression of autophagy is protective in high glucose-induced cardiomyocyte injury. Autophagy8: 577–592, 2012.
32. Kroemer G, Levine B. Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol9: 1004–1010, 2008.
33. Kubli DA, Gustafsson AB. Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res111: 1208–1221, 2012.
34. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell132: 27–42, 2008.
35. Loos B, Engelbrecht AM, Lockshin RA, Klionsky DJ, Zakeri Z. The variability of autophagy and cell death susceptibility: unanswered questions. Autophagy9: 1270–1285, 2013.
36. Matheson PJ, Hurt RT, Franklin GA, McClain CJ, Garrison RN. Obesity-induced hepatic hypoperfusion primes for hepatic dysfunction after resuscitated hemorrhagic shock. Surgery146: 739–747, 2009.
37. Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T, Levine B, Sadoshima J. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res100: 914–922, 2007.
38. Meyer G, Czompa A, Reboul C, Csepanyi E, Czegledi A, Bak I, Balla G, Balla J, Tosaki A, Lekli I. The cellular autophagy markers beclin-1 and LC3B-II are increased during reperfusion in fibrillated mouse hearts. Curr Pharm Design19: 6912–6918, 2013.
39. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature451: 1069–1075, 2008.
40. Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy3: 542–545, 2007.
41. Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM, Zhou YQ, Riazi AM, Baggio LL, Henkelman RM, Husain M, Drucker DJ. GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes58: 975–983, 2009.
42. Padmasekar M, Lingwal N, Samikannu B, Chen C, Sauer H, Linn T. Exendin-4 protects hypoxic islets from oxidative stress and improves islet transplantation outcome. Endocrinology154: 1424–1433, 2013.
43. Rautou PE, Mansouri A, Lebrec D, Durand F, Valla D, Moreau R. Autophagy in liver diseases. J Hepatol53: 1123–1134, 2010.
44. Sharma S, Mells JE, Fu PP, Saxena NK, Anania FA. GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. PLos One6: e25269, 2011.
45. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM, Czaja MJ. Autophagy regulates lipid metabolism. Nature458: 1131–1135, 2009.
46. Tacke F, Trautwein C. Controlling autophagy: a new concept for clearing liver disease. Hepatology53: 356–358, 2011.
47. Takagi H, Matsui Y, Sadoshima J. The role of autophagy in mediating cell survival and death during ischemia and reperfusion in the heart. Antioxid Redox Signal9: 1373–1381, 2007.
48. Tanida I, Ueno T, Kominami E. LC3 and autophagy. Methods Mol Biol445: 77–88, 2008.
49. Turkmen K, Martin J, Akcay A, Nguyen Q, Ravichandran K, Faubel S, Pacic A, Ljubanovic D, Edelstein CL, Jani A. Apoptosis and autophagy in cold preservation ischemia. Transplantation91: 1192–1197, 2011.
50. Vardanian AJ, Busuttil RW, Kupiec-Weglinski JW. Molecular mediators of liver ischemia and reperfusion injury: a brief review. Mol Med14: 337–345, 2008.
51. Vetelainen R, van Vliet AK, van Gulik TM. Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy. Ann Surg245: 44–50, 2007.
52. Wang D, Ma Y, Li Z, Kang K, Sun X, Pan S, Wang J, Pan H, Liu L, Liang D, Jiang H. The role of AKT1 and autophagy in the protective effect of hydrogen sulphide against hepatic ischemia/reperfusion injury in mice. Autophagy8: 954–962, 2012.
53. Wang JH, Ahn IS, Fischer TD, Byeon JI, Dunn WA Jr, Behrns KE, Leeuwenburgh C, Kim JS. Autophagy suppresses age-dependent ischemia and reperfusion injury in livers of mice. Gastroenterology141: 2188–2199, 2011.
54. Wang Y, Singh R, Massey AC, Kane SS, Kaushik S, Grant T, Xiang Y, Cuervo AM, Czaja MJ. Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus. J Biol Chem283: 4766–4777, 2008.
55. Wang Y, Singh R, Xiang Y, Czaja MJ. Macroautophagy and chaperone-mediated autophagy are required for hepatocyte resistance to oxidant stress. Hepatology52: 266–277, 2010.
56. Won H, Nandakumar V, Yates P, Sanchez S, Jones L, Huang XF, Chen SY. Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1. Blood. In press.
57. Yang PM, Liu YL, Lin YC, Shun CT, Wu MS, Chen CC. Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res70: 7699–7709, 2010.
58. Yin XM, Ding WX, Gao W. Autophagy in the liver. Hepatology47: 1773–1785, 2008.
59. Zhang Y, Moschetta M, Huynh D, Tai YT, Zhang W, Mishima Y, Ring JE, Tam WF, Xu Q, Maiso P, Reagan M, Sahin I, Sacco A, Manier S, Aljawai Y, Glavey S, Munshi NC, Anderson KC, Pachter J, Roccaro AM, Ghobrial IM. Pyk2 promotes tumor progression in multiple myeloma. Blood. In press.